Published in Rheumatol Int on May 29, 2010
Genetic variant associations of human SP-A and SP-D with acute and chronic lung injury. Front Biosci (Landmark Ed) (2012) 1.04
Surfactant protein D, Club cell protein 16, Pulmonary and activation-regulated chemokine, C-reactive protein, and Fibrinogen biomarker variation in chronic obstructive lung disease. Respir Res (2014) 0.79
Endurance exercise training decreased serum levels of surfactant protein D and improved aerobic fitness of obese women with type-2 diabetes. Diabetol Metab Syndr (2017) 0.75
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum (1988) 111.05
Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn (Stockh) (1977) 9.55
Exercise and the immune system: regulation, integration, and adaptation. Physiol Rev (2000) 3.42
Lung epithelium-specific proteins: characteristics and potential applications as markers. Am J Respir Crit Care Med (1999) 2.32
Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum (1992) 2.31
Localization of lung surfactant protein D on mucosal surfaces in human tissues. J Immunol (2000) 1.95
Circadian rhythms in rheumatoid arthritis: implications for pathophysiology and therapeutic management. Arthritis Rheum (2007) 1.78
Diurnal rhythms of pro-inflammatory cytokines: regulation by plasma cortisol and therapeutic implications. Cytokine (1998) 1.63
Pulmonary surfactant proteins A and D enhance neutrophil uptake of bacteria. Am J Physiol (1998) 1.62
Surfactant protein D is expressed and modulates inflammatory responses in human coronary artery smooth muscle cells. Am J Physiol Heart Circ Physiol (2008) 1.47
A common polymorphism in the SFTPD gene influences assembly, function, and concentration of surfactant protein D. J Immunol (2005) 1.36
Surfactant protein D is present in human tear fluid and the cornea and inhibits epithelial cell invasion by Pseudomonas aeruginosa. Infect Immun (2005) 1.29
Exercise and circulating cortisol levels: the intensity threshold effect. J Endocrinol Invest (2008) 1.24
Surfactant protein A and surfactant protein D variation in pulmonary disease. Immunobiology (2007) 1.21
Immunolocalization of surfactant protein-D (SP-D) in human fetal, newborn, and adult tissues. J Histochem Cytochem (2002) 1.20
Adaptation into Danish of the Stanford Health Assessment Questionnaire (HAQ) and the Rheumatoid Arthritis Quality of Life Scale (RAQoL). Scand J Rheumatol (2001) 1.19
Immunocytochemical localization of surfactant protein D (SP-D) in type II cells, Clara cells, and alveolar macrophages of rat lung. J Histochem Cytochem (1992) 1.17
Circadian rhythms in arthritis: hormonal effects on the immune/inflammatory reaction. Autoimmun Rev (2007) 1.13
Surfactant protein D (SP-D) serum levels in patients with community-acquired pneumonia. Clin Immunol (2003) 1.12
Reduced influenza viral neutralizing activity of natural human trimers of surfactant protein D. Respir Res (2007) 1.10
IL-4 and IL-13 form a negative feedback circuit with surfactant protein-D in the allergic airway response. J Immunol (2006) 1.10
Surfactant protein D: subcellular localization in nonciliated bronchiolar epithelial cells. Am J Physiol (1992) 1.09
Surfactant protein A and D differently regulate the immune response to nonmucoid Pseudomonas aeruginosa and its lipopolysaccharide. Am J Respir Cell Mol Biol (2003) 1.09
Collectins and collectin receptors in innate immunity. APMIS Suppl (2000) 1.08
Circadian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: a north and south Europe comparison. Ann Rheum Dis (2005) 1.04
Surfactant protein D in the female genital tract. Mol Hum Reprod (2004) 0.99
Measurement of pulmonary status and surfactant protein levels during dexamethasone treatment of neonatal respiratory distress syndrome. Thorax (1996) 0.96
[Determination of IgM rheumatoid factors by enzyme-linked immunosorbent assay (ELISA)]. Ugeskr Laeger (1986) 0.95
Melatonin in rheumatoid arthritis: synovial macrophages show melatonin receptors. Ann N Y Acad Sci (2002) 0.94
IL-4 increases surfactant and regulates metabolism in vivo. Am J Physiol Lung Cell Mol Physiol (2000) 0.92
Long-term stability and circadian variation in circulating levels of surfactant protein D. Immunobiology (2009) 0.91
Regulation of surfactant protein D in human fetal lung. Am J Respir Cell Mol Biol (1996) 0.91
Enzyme-linked immunosorbent assay using F(ab')2 fragment for the detection of human pulmonary surfactant protein D in sera. Clin Chim Acta (1997) 0.88
Surfactant protein d, a marker of lung innate immunity, is positively associated with insulin sensitivity. Diabetes Care (2010) 0.87
Serum cortisol reduction and abnormal prolactin and CD4+/CD8+ T-cell response as a result of controlled exercise in patients with rheumatoid arthritis and systemic lupus erythematosus despite unaltered muscle energetics. Rheumatology (Oxford) (2003) 0.86
Surfactant protein D is proatherogenic in mice. Am J Physiol Heart Circ Physiol (2005) 0.85
ACTH, cortisol and prolactin in active rheumatoid arthritis. Clin Rheumatol (2002) 0.84
Hypothalamic-pituitary-adrenal axis activity in patients with rheumatoid arthritis. Clin Exp Rheumatol (2005) 0.83
A role for surfactant protein D in innate immunity of the human prostate. Prostate (2005) 0.82
Immunolocalization of surfactant protein A and D in sinonasal mucosa. Am J Rhinol (2006) 0.78
Circulating surfactant protein D is decreased in early rheumatoid arthritis: a 1-year prospective study. Scand J Immunol (2008) 0.78
A second serine protease associated with mannan-binding lectin that activates complement. Nature (1997) 3.64
The concentration of the C-type lectin, mannan-binding protein, in human plasma increases during an acute phase response. Clin Exp Immunol (1992) 1.98
Localization of lung surfactant protein D on mucosal surfaces in human tissues. J Immunol (2000) 1.95
Salivary agglutinin, which binds Streptococcus mutans and Helicobacter pylori, is the lung scavenger receptor cysteine-rich protein gp-340. J Biol Chem (2000) 1.89
MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA). Ann Rheum Dis (2008) 1.71
Cloning of gp-340, a putative opsonin receptor for lung surfactant protein D. Proc Natl Acad Sci U S A (1999) 1.69
Isolation and characterization of a new member of the scavenger receptor superfamily, glycoprotein-340 (gp-340), as a lung surfactant protein-D binding molecule. J Biol Chem (1997) 1.68
The occurrence of psoriatic arthritis in Denmark. Ann Rheum Dis (2008) 1.55
IVIG treatment for progressive stroke in the primary antiphospholipid antibody syndrome. Lupus (2004) 1.52
Serum YKL-40 concentrations in patients with rheumatoid arthritis: relation to disease activity. Rheumatology (Oxford) (1999) 1.35
Binding of host collectins to the pathogenic yeast Cryptococcus neoformans: human surfactant protein D acts as an agglutinin for acapsular yeast cells. Infect Immun (1995) 1.32
DMBT1 encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer. Cancer Res (2000) 1.32
Expression of the carbohydrate recognition domain of lung surfactant protein D and demonstration of its binding to lipopolysaccharides of gram-negative bacteria. Biochem Biophys Res Commun (1994) 1.20
YKL-40, a matrix protein of specific granules in neutrophils, is elevated in serum of patients with community-acquired pneumonia requiring hospitalization. J Infect Dis (1999) 1.15
Mortality and causes of death of 513 Danish patients with systemic lupus erythematosus. Scand J Rheumatol (1999) 1.15
Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients. Genes Immun (2001) 1.11
Purification and characterization of two mannan-binding lectins from mouse serum. J Immunol (2000) 1.07
Coexistence of temporal arteritis and rheumatoid arthritis. J Rheumatol (1983) 1.06
A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets. Clin Rheumatol (1998) 1.05
Structural aspects of collectins and receptors for collectins. Immunobiology (1998) 1.05
Ankylosing spondylitis in Danish and Norwegian twins: occurrence and the relative importance of genetic vs. environmental effectors in disease causation. Scand J Rheumatol (2008) 1.03
Deleted in Malignant Brain Tumors 1 is a versatile mucin-like molecule likely to play a differential role in digestive tract cancer. Cancer Res (2001) 1.03
Low field dedicated magnetic resonance imaging in untreated rheumatoid arthritis of recent onset. Ann Rheum Dis (2001) 1.02
HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus. Tissue Antigens (2008) 1.01
Human salivary agglutinin binds to lung surfactant protein-D and is identical with scavenger receptor protein gp-340. Biochem J (2001) 1.01
Serum aminoterminal type III procollagen peptide reflects repair after acute myocardial infarction. Circulation (1990) 1.00
The genomic structure of the DMBT1 gene: evidence for a region with susceptibility to genomic instability. Oncogene (1999) 0.99
Surfactant protein D in the female genital tract. Mol Hum Reprod (2004) 0.99
Systemic lupus erythematosus in Denmark: clinical and epidemiological characterization of a county-based cohort. Scand J Rheumatol (1998) 0.97
Structural similarity between lung surfactant protein D and conglutinin. Two distinct, C-type lectins containing collagen-like sequences. Eur J Biochem (1993) 0.96
Measurement of pulmonary status and surfactant protein levels during dexamethasone treatment of neonatal respiratory distress syndrome. Thorax (1996) 0.96
Bone loss in rheumatoid arthritis. Influence of disease activity, duration of the disease, functional capacity, and corticosteroid treatment. Scand J Rheumatol (1996) 0.95
Cloning of a novel scavenger receptor cysteine-rich type I transmembrane molecule (M160) expressed by human macrophages. J Immunol (2000) 0.95
Microfibril-associated protein 4 binds to surfactant protein A (SP-A) and colocalizes with SP-A in the extracellular matrix of the lung. Scand J Immunol (2006) 0.95
Seromarkers of collagen I and III metabolism in active Crohn's disease. Relation to disease activity and response to therapy. Gut (1995) 0.94
Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol (1995) 0.94
Regulation of pancreatic islet gene expression in mouse islets by pregnancy. J Endocrinol (2010) 0.94
Low-cost, low-field dedicated extremity magnetic resonance imaging in early rheumatoid arthritis: a 1-year follow-up study. Ann Rheum Dis (2006) 0.94
Bovine conglutinin binds to an oligosaccharide determinant presented by iC3b, but not by C3, C3b or C3c. Immunology (1994) 0.93
Reliability and responsiveness of dynamic contrast-enhanced magnetic resonance imaging in rheumatoid arthritis. Scand J Rheumatol (2012) 0.93
Urinary hydroxypyridinium cross-links of collagen in rheumatoid arthritis. Relation to disease activity and effects of methylprednisolone. Br J Rheumatol (1994) 0.93
Differentiation between early rheumatoid arthritis patients and healthy persons by conventional and dynamic contrast-enhanced magnetic resonance imaging. Scand J Rheumatol (2013) 0.92
Autoantibodies and self-reported health complaints in relatives of systemic lupus erythematosus patients: a community based approach. Lupus (2004) 0.92
A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value. Clin Rheumatol (1998) 0.92
Microfibril-associated protein 4 is present in lung washings and binds to the collagen region of lung surfactant protein D. J Biol Chem (1999) 0.92
Expression of the innate defense receptor S5D-SRCRB in the urogenital tract. Tissue Antigens (2014) 0.92
Surfactant protein D of the innate immune defence is inversely associated with human obesity and SP-D deficiency infers increased body weight in mice. Scand J Immunol (2006) 0.92
Serum amino-terminal type III procollagen peptide in rheumatoid arthritis. Relationship to disease activity, treatment, and development of joint erosions. Arthritis Rheum (1986) 0.91
The scavenger receptor, cysteine-rich domain-containing molecule gp-340 is differentially regulated in epithelial cell lines by phorbol ester. Clin Exp Immunol (2002) 0.90
Dynamic gadolinium-enhanced magnetic resonance imaging allows accurate assessment of the synovial inflammatory activity in rheumatoid arthritis knee joints: a comparison with synovial histology. Scand J Rheumatol (2012) 0.90
An enzyme-linked immunosorbent assay (ELISA) for quantification of human collectin 11 (CL-11, CL-K1). J Immunol Methods (2011) 0.89
Soluble macrophage-derived CD163 is a marker of disease activity and progression in early rheumatoid arthritis. Clin Exp Rheumatol (2011) 0.89
Biological variation in circulating levels of mannan-binding lectin (MBL) and MBL-associated serine protease-2 and the influence of age, gender and physical exercise. Scand J Immunol (2007) 0.89
A putative regulatory polymorphism in PD-1 is associated with nephropathy in a population-based cohort of systemic lupus erythematosus patients. Lupus (2004) 0.89
Immunohistochemical detection of salivary agglutinin/gp-340 in human parotid, submandibular, and labial salivary glands. J Dent Res (2002) 0.89
Magnetic resonance imaging and bone scintigraphy in the differential diagnosis of unclassified arthritis. Ann Rheum Dis (2007) 0.89
Purification and characterization of mannan-binding protein from mouse serum. Scand J Immunol (1994) 0.88
Fibronectin in experimental granulation tissue. Acta Pathol Microbiol Immunol Scand A (1982) 0.88
Fetal antigen 1 (FA1), a circulating member of the epidermal growth factor (EGF) superfamily: ELISA development, physiology and metabolism in relation to renal function. Clin Chim Acta (1997) 0.88
Assessment of the biological variation of plasma tissue inhibitor of metalloproteinases-1. Int J Biol Markers (2008) 0.87
Occurrence of systemic lupus erythematosus in a Danish community: an 8-year prospective study. Scand J Rheumatol (2009) 0.87
Structural characterization of bovine collectin-43. Eur J Biochem (1997) 0.87
Interaction of calreticulin with CD40 ligand, TRAIL and Fas ligand. Scand J Immunol (2007) 0.87
Procollagen type III aminoterminal peptide in serum in idiopathic myelofibrosis and allied conditions: relation to disease activity and effect of chemotherapy. Am J Hematol (1990) 0.86
Adaptation of the Bath measures on disease activity and function in ankylosing spondylitis into Danish. Scand J Rheumatol (2007) 0.86
Purification, characterization and immunolocalization of porcine surfactant protein D. Immunology (2005) 0.86
Umbilical vein catheterization and portal hypertension. Acta Paediatr Scand (1976) 0.86
Collagen metabolites in the peripheral and splanchnic circulation of patients with Crohn disease. Scand J Gastroenterol (2001) 0.86
Periarticular and generalised bone loss in patients with early rheumatoid arthritis: influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trial. Ann Rheum Dis (2013) 0.86
Prognostic value of renal biopsy and clinical variables in patients with lupus nephritis and normal serum creatinine. Scand J Rheumatol (1999) 0.85
Structural characterisation of human proteinosis surfactant protein A. Biochim Biophys Acta (2000) 0.85
Increased soluble programmed death-1 (sPD-1) is associated with disease activity and radiographic progression in early rheumatoid arthritis. Scand J Rheumatol (2013) 0.85
Antiviral activity of bovine collectins against rotaviruses. J Gen Virol (1998) 0.85
Diminished ability of erythrocytes from patients with systemic lupus erythematosus to limit opsonized immune complex deposition on leukocytes and activation of granulocytes. Arthritis Rheum (1998) 0.85
Increasing antiviral activity of surfactant protein d trimers by introducing residues from bovine serum collectins: dissociation of mannan-binding and antiviral activity. Scand J Immunol (2010) 0.84
Splanchnic and renal extraction of circulating type III procollagen aminoterminal propeptide in patients with normal liver function and in patients with alcoholic cirrhosis. Hepatology (1990) 0.84
Serum levels of aminoterminal type III procollagen peptide and hyaluronan predict mortality in systemic sclerosis. Scand J Rheumatol (1992) 0.83
Primary structure of bovine collectin-43 (CL-43). Comparison with conglutinin and lung surfactant protein-D. J Biol Chem (1994) 0.83
Hypercalcemia in idiopathic myelofibrosis: modulation of calcium and collagen homeostasis by 1,25-dihydroxyvitamin D3. Am J Hematol (1992) 0.83
Collectins, collectin receptors and the lectin pathway of complement activation. Clin Exp Immunol (1994) 0.83
Serum aminoterminal type III procollagen peptide in inflammatory and degenerative rheumatic disorders. Clin Rheumatol (1988) 0.83